StatSure Diagnostic Systems (SSUR)

[Ubertino]

FDA Approves CLIA Waiver for StatSure’s Patented Barrel Technology for Rapid HIV Testing

November 6, 2007
A valuation increase strengthens “BUY” ranking - We are increasing our modeled SSUR.OB’s valuation to $1.66

SSUR.OB’s stock price of $0.40 and market capitalization of $15.27 m is low when compared with its near and long-term potential and we are recommending a “BUY” with a valuation of $1.66.


http://www.scimitarequity.com/research/SSUR.OB_Mid-Quarter_Review.pdf